Prognostic Significance of Stromelysin-3 and Tissue Inhibitor of Matrix Metalloproteinase-2 in Esophageal Cancer

Publisher： Karger

E-ISSN： 1423-0232|67|3-4|300-309

ISSN： 0030-2414

Source： Oncology, Vol.67, Iss.3-4, 2004-11, pp. : 300-309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sputum matrix metalloproteinase‐8 and ‐9 and tissue inhibitor of metalloproteinase‐1 in bronchiectasis: Clinical correlates and prognostic implications

By  

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 7, 2015-10 ,pp. : 1073-1081

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinicopathological Significance of Stromelysin-3 Expression in Colorectal Cancer

By  

Oncology, Vol. 67, Iss. 1, 2004-10 ,pp. : 67-72

Karger

Access to resources Recommend Favorite

Cutaneous tissue expressions of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 are associated with a high degree of disability at diagnosis of hanseniasis

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 9, 2015-09 ,pp. : e361-e362

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tissue Inhibitor of Metalloproteinase-1: Actions beyond Matrix Metalloproteinase Inhibition

By  

Cardiology, Vol. 132, Iss. 3, 2015-0 ,pp. : 147-150

Karger

Access to resources Recommend Favorite

Fibrogenic and Inflammatory Cytokines Modulate mRNA Expressions of Matrix Metalloproteinase-3 and Tissue Inhibitor of Metalloproteinase-3 in Type II Pneumocytes

By  

Respiration, Vol. 68, Iss. 5, 2001-10 ,pp. : 509-516

Karger

Access to resources Recommend Favorite